Skip to main content

Identifying people with tuberculosis and linking to care: finding the missing millions

Guest editors: Rachael Burke and Finn McQuaid

New Content ItemDespite ongoing efforts, tuberculosis (TB) remains the second leading cause of death from infectious diseases (after COVID-19) and caused 1.6 million deaths in 2021. Of the 10.6 million people estimated to have developed TB in 2021, only 6.4 million of them started treatment and were notified to National TB Programmes - with this treatment gap made even worse by the impact of COVID-19 on TB diagnosis, treatment and care. Research and insights into TB disease diagnosis, incidence and prevalence, as well as advances in implementation of early detection, prevention, treatment and care are important to inform global and public health efforts to ‘Find the missing millions’ and achieve End TB goals. 

To capture advances and global efforts in this multi-disciplinary area, BMC Global and Public Health is pleased to announce a call for papers for our upcoming collection entitled ‘Identifying people with tuberculosis and linking to care: finding the missing millions', guest edited by Dr. Rachael Burke, from the Malawi Liverpool Wellcome Trust, and Dr. Finn McQuaid, from the London School of Hygiene and Tropical Medicine

We are now inviting the submission of Research manuscripts of outstanding interest covering the breadth of multi-disciplinary studies and advances in diagnostics, epidemiology, policy, frameworks, and implementation in this area, including:

  ● Case finding and screening for TB
  ● Early detection of TB  
  ● Novel diagnostics (including diagnostic algorithms) to identify people with TB
  ● Linkage of people from diagnosis to TB care 
  ● TB disease outcomes and the impact of screening or new diagnostic strategies on these outcomes
  ● Modeling the impact of screening and other strategies to identify people with TB on TB epidemiology
  ● Economic impact and cost-effectiveness studies
  ● Values and preferences of people accessing TB testing or screening
  ● Effect of crises on TB screening, diagnosis and linkage to care (including COVID-19, conflict, humanitarian emergencies, and other challenging circumstances)

We encourage work from local, regional and global partnerships and collaboration among scientists from multi-disciplinary fields. We ask that authors be attentive to the use of non-stigmatizing/preferred language in their manuscripts as outlined in the language guide by The Stop TB Partnership. 

Submission deadline: 29 December 2023

To submit your manuscript, please use the BMC Global and Public Health online submission system and indicate in your covering letter that you would like the article to be considered for the ‘Identifying people with tuberculosis and linking to care: finding the missing millions' collection. If you would like to enquire about the suitability of a manuscript for consideration, please email

All articles submitted to Collections are peer reviewed in line with the journal’s standard peer review policy and are subject to all of the journal’s standard editorial and publishing policies. This includes the journal’s policy on competing interests. 

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.

  1. To reach the millions of people with tuberculosis (TB) undiagnosed each year, there is an important need to provide people-centered screening and testing services. Despite people-centered care being a key pill...

    Authors: Andrew D. Kerkhoff, Nora S. West, Maria del Mar Castro, David Branigan, Devasahayam J. Christopher, Claudia M. Denkinger, Nguyen Viet Nhung, Grant Theron, William Worodria, Charles Yu, Monde Muyoyeta and Adithya Cattamanchi
    Citation: BMC Global and Public Health 2023 1:27
  2. People with subclinical tuberculosis (TB) have microbiological evidence of disease caused by Mycobacterium tuberculosis, but either do not have or do not report TB symptoms. The relationship between human immunod...

    Authors: Naomi Carter, Emily L. Webb, Limakatso Lebina, Kegaugetswe Motsomi, Zama Bosch, Neil A. Martinson and Peter MacPherson
    Citation: BMC Global and Public Health 2023 1:21
  3. Tuberculosis (TB) is a leading cause of death in children, but many cases are never diagnosed. Microbiological diagnosis of pulmonary TB is challenging in young children who cannot spontaneously expectorate sp...

    Authors: Nisreen Khambati, Rinn Song, Emily Lai-Ho MacLean, Mikashmi Kohli, Laura Olbrich and Else Margreet Bijker
    Citation: BMC Global and Public Health 2023 1:18
  4. To better evaluate the cost-effectiveness of active case finding for tuberculosis, a framework for estimating long-term cost and impact is needed. We outline such a framework and highlight the need for consens...

    Authors: David W. Dowdy and Hojoon Sohn
    Citation: BMC Global and Public Health 2023 1:20
  5. Ultra-portable X-ray devices with artificial intelligence (AI) are increasingly used to screen for tuberculosis (TB). Few studies have documented their performance. We aimed to evaluate the performance of ches...

    Authors: Stephen John, Suraj Abdulkarim, Salisu Usman, Md. Toufiq Rahman and Jacob Creswell
    Citation: BMC Global and Public Health 2023 1:17
  6. Reducing malnutrition through food supplementation is a critical component of the WHO End Tuberculosis (TB) strategy. A results-based financing (RBF) initiative in Madhya Pradesh, India—called Mukti—introduced...

    Authors: Embry Howell, Rama Rao Dammala, Pratibha Pandey, Darcy Strouse, Atul Sharma, Neeta Rao, Sudheer Nadipally, Amar Shah, Varsha Rai and Russell Dowling
    Citation: BMC Global and Public Health 2023 1:13